产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量

抱歉,暂无牌价信息

晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

1809336-19-3

中文名称

(R)-OR-S1

英文名称

(R)-OR-S1

别名

(R)-OR-S1;1,3-Benzodioxole-5-carboxamide, 7-bromo-N-[(1,2-dihydro-4,6-dimethyl-2-oxo-3-pyridinyl)methyl]-2-[trans-4-(dimethylamino)cyclohexyl]-2,4-dimethyl-, (2R)-

标准英文名

(S)-7-bromo-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-(4-(dimethylamino)cyclohexyl)-2,4-dimethylbenzo[d][1,3]dioxole-5-carboxamide

分子式

C26H34BrN3O4

分子量

532.48

精确分子量

531.17

SMILES

O=C(C1=CC(Br)=C(O[C@@](C)(C2CCC(N(C)C)CC2)O3)C3=C1C)NCC4=C(C)C=C(C)NC4=O

标准SMILES

CC1=CC(C)=C(CNC(=O)C2=CC(Br)=C3O[C@](C)(OC3=C2C)C2CCC(CC2)N(C)C)C(=O)N1

用途

(R)-OR-S1 is a stereoisomer of OR-S1 and functions as a highly selective dual inhibitor of EZH1 and EZH2 methyltransferases. It induces differentiation and apoptosis in acute myeloid leukemia (AML) cells. The compound shows potential for clinical application in AML treatment, as it does not cause significant myelosuppression and allows normal hematopoiesis even after prolonged inhibition. It can be used alone or in combination with cytarabine for PRC2-targeted therapy in AML patients.

InChIKey

CHJLMVBYELJCLC-WLYVOJLOSA-N

安全信息

SureRoute逆合成路线

1.  1809336-19-3 逆合成路线 1

—
—
—
—
ACHUGA997
1809336-19-3
来源: SureRoute

2.  1809336-19-3 逆合成路线 2

—
—
ACEUTY084
1173081-96-3
ACHUGA997
1809336-19-3
来源: SureRoute

3.  1809336-19-3 逆合成路线 3

—
—
ACEUTY084
1173081-96-3
ACHUGA997
1809336-19-3
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手